Sid Gilman

Last updated

Sidney Gilman is an American retired physician, neurologist, and educator. He is an expert on Alzheimer's disease and spent the majority of his career at the University of Michigan, its medical school, and its Health System. [1]

Contents

Early life, family and education

Gilman was raised in California. In 1950, he graduated from Huntington Park High School in Huntington Park, California. [2]

He graduated from University of California, Los Angeles (UCLA) for his undergraduate degree in 1954 and its medical school in 1957, [3] [4] receiving the highest academic honors. During his college years, he was a gymnastics athlete. [2]

He completed his medical residency at Boston City Hospital and a neurology fellowship at Harvard Medical School. [4] [5] :2 He completed a neurophysiology fellowship from 1958 to 1960 at the National Institutes of Health in Bethesda, Maryland. [2]

Career

Dr. Gilman taught at Harvard Medical School after he completed his research fellowship. [2] He worked at the National Institutes of Health and performed authoritative research regarding brain control of motor functions and muscle tone. [3] He began working at Columbia University in 1968, and in 1976 he was named the first H. Houston Merritt chair in research neurology. [3] In 1977, [3] however, he became professor, chair and chief of service of neurology at the University of Michigan Medical School. [1] [6] The hospital's neurology service named after him, as well as a lecture series. [6] He published hundreds of articles and delivered decades of lectures. [1] His university salary eventually was over US$300,000. [6]

His research and areas of interest have involved brain and spinal cord injury, neurological degenerative diseases, and the effects of alcohol on the brain, [3] R.E.M. sleep disorders, Parkinson's disease and Lewy body disease, and cardiac denervation among many other subjects. [2] Some of his research has been in connection with many of the world's largest pharmaceutical companies, including Merck, Pfizer, and Johnson & Johnson. [1] In the 2000s, he also worked as a consultant for Wall Street investors including Pequot Capital and Longitude Capital. [1] These jobs increased Gilman's income by more than US$200,000 per year. [6]

Gilman has held numerous editorial and advisory board positions with major scientific publications, including Neurology , Journal of Neuropathology and Experimental Neurology , Applied Neurophysiology , Experimental Neurology , Annals of Neurology , Neurobiology of Disease , and Alzheimer Disease & Associated Disorders .

Bapineuzumab controversy

In 2013, Gilman was implicated in the insider trading scandal concerning the Alzheimer's medication bapineuzumab, a drug which was being developed by Wyeth and Élan. [1] [6] In exchange for lighter punishment, Gilman agreed to testify and implicate Mathew Martoma of CR Intrinsic, a company affiliated with the hedge fund SAC Capital Advisors. [1] It was considered "the most lucrative insider trading scheme in history." [6] Gilman served no prison time and returned his earnings with interest. [6]

As a result, the University of Michigan disassociated itself from him. [5] :3

Personal life

Gilman and his first wife Linda had two sons, Jeff and Todd. [6] The marriage ended in divorce. [6] Jeff, like his paternal grandmother, committed suicide. [6]

In 1984 Sid Gilman married Carol Barbour, a psychoanalyst. [5] :2

After being diagnosed with lymphoma, he received chemotherapy treatment successfully. [6]

Honors and awards

Publications

Related Research Articles

<span class="mw-page-title-main">Neurology</span> Medical specialty dealing with disorders of the nervous system

Neurology is the branch of medicine dealing with the diagnosis and treatment of all categories of conditions and disease involving the nervous system, which comprises the brain, the spinal cord and the peripheral nerves. Neurological practice relies heavily on the field of neuroscience, the scientific study of the nervous system.

Clinical neurophysiology is a medical specialty that studies the central and peripheral nervous systems through the recording of bioelectrical activity, whether spontaneous or stimulated. It encompasses both research regarding the pathophysiology along with clinical methods used to diagnose diseases involving both central and peripheral nervous systems. Examinations in the clinical neurophysiology field are not limited to tests conducted in a laboratory. It is thought of as an extension of a neurologic consultation. Tests that are conducted are concerned with measuring the electrical functions of the brain, spinal cord, and nerves in the limbs and muscles. It can give the precise definition of site, the type and degree of the lesion, along with revealing the abnormalities that are in question. Due to these abilities, clinical neurophysiology is used to mainly help diagnose diseases rather than treat them.

<span class="mw-page-title-main">Stanley B. Prusiner</span> American neurologist and biochemist

Stanley Ben Prusiner is an American neurologist and biochemist. He is the director of the Institute for Neurodegenerative Diseases at University of California, San Francisco (UCSF). Prusiner discovered prions, a class of infectious self-reproducing pathogens primarily or solely composed of protein, considered by many as a heretical idea when first proposed. He received the Albert Lasker Award for Basic Medical Research in 1994 and the Nobel Prize in Physiology or Medicine in 1997 for prion research developed by him and his team of experts beginning in the early 1970s.

<span class="mw-page-title-main">National Institute of Neurological Disorders and Stroke</span> Department of the U.S. National Institutes of Health

The National Institute of Neurological Disorders and Stroke (NINDS) is a part of the U.S. National Institutes of Health (NIH). It conducts and funds research on brain and nervous system disorders and has a budget of just over US$2.03 billion. The mission of NINDS is "to reduce the burden of neurological disease—a burden borne by every age group, every segment of society, and people all over the world". NINDS has established two major branches for research: an extramural branch that funds studies outside the NIH, and an intramural branch that funds research inside the NIH. Most of NINDS' budget goes to fund extramural research. NINDS' basic science research focuses on studies of the fundamental biology of the brain and nervous system, genetics, neurodegeneration, learning and memory, motor control, brain repair, and synapses. NINDS also funds clinical research related to diseases and disorders of the brain and nervous system, e.g. AIDS, Alzheimer's disease, epilepsy, muscular dystrophy, multiple sclerosis, Parkinson's disease, spinal cord injury, stroke, and traumatic brain injury.

<span class="mw-page-title-main">Michigan Medicine</span> Medical center and school of the University of Michigan in Ann Arbor, MI

Michigan Medicine is the academic medical center of the University of Michigan in Ann Arbor. It consists of the University of Michigan Medical School and the University of Michigan Health hospitals and healthcare centers.

Sir John Anthony Hardy is a human geneticist and molecular biologist at the Reta Lila Weston Institute of Neurological Studies at University College London with research interests in neurological diseases.

Bapineuzumab is a humanized monoclonal antibody that acts on the nervous system and may have potential therapeutic value for the treatment of Alzheimer's disease and possibly glaucoma. However, in 2012 it failed to produce significant cognitive improvements in patients in two major trials, despite lowering key biomarkers of AD, amyloid brain plaque and hyperphosphorylated tau protein in CSF.

<span class="mw-page-title-main">Kenneth Heilman</span>

Kenneth M. Heilman is an American behavioral neurologist He is considered one of the fathers of modern-day behavioral neurology.

<span class="mw-page-title-main">Eva Feldman</span> American neurologist

Eva Lucille Feldman is an American physician-scientist who is a leading authority on neurodegenerative disease. She serves as the Russell N. DeJong Professor of Neurology at the University of Michigan, as well as Director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine. She was also named the James W. Albers Distinguished University Professor of Neurology.

Neuroepidemiology is a science of incidence, prevalence, risk factors, natural history and prognosis of neurological disorders, as well as of experimental neuroepidemiology, which is research based on clinical trials of effectiveness or efficacy of various interventions in neurological disorders.

Steven T. DeKosky is the Aerts-Cosper Professor of Alzheimer's Research at the University of Florida (UF) College of Medicine, deputy director of UF’s Evelyn F. and William L. McKnight Brain Institute (MBI) and associate director of the 1Florida Alzheimer’s Disease Research Center.

Samuel E. Gandy, is a neurologist, cell biologist, Alzheimer's disease (AD) researcher and expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. His team discovered the first drugs that could lower the formation of amyloid.

<span class="mw-page-title-main">Anne B. Young</span> American neuroscientist

Anne Buckingham Young is an American physician and neuroscientist who has made major contributions to the study of neurodegenerative diseases, with a focus on movement disorders like Huntington's disease and Parkinson's disease. Young completed her undergraduate studies at Vassar College and earned a dual MD/PhD from Johns Hopkins Medical School. She has held faculty positions at University of Michigan and Harvard University. She became the first female chief of service at Massachusetts General Hospital when she was appointed Chief of Neurology in 1991. She retired from this role and from clinical service in 2012. She is a member of many academic societies and has won numerous awards. Young is also the only person to have been president of both the international Society for Neuroscience and the American Neurological Association.

The Mischer Neuroscience Institute is a combined research and education effort between the Vivian L. Smith Department of Neurosurgery and the Department of Neurology at McGovern Medical School at UTHealth Houston and Memorial Hermann Hospital. Located in Houston, the Institute draws patients from around the world for specialized treatment of diseases of the brain and spine. It was the first center in Texas and one of only a few institutions in the country to fully integrate neurology, neurosurgery, neuroradiology, neuro-oncology, spine surgery, pain medicine and neurorehabilitation.

Barry Jordan is an American neurologist. He currently serves as the assistant medical director at Burke Rehabilitation Hospital in White Plains, N.Y. He is also the director of neurorehabilitation and director of the Memory Evaluation Treatment Service at Burke. Jordan is a board certified neurologist specializing in sports neurology, Alzheimer's disease, and traumatic brain injury. Jordan has been at Burke Rehabilitation Hospital since 1999.

<span class="mw-page-title-main">Rajiv Ratan</span> American physician

Rajiv Ratan is an Indian American academic, professor, administrator and scientist based in New York. He is the Burke Professor of Neurology and Neuroscience at Weill Cornell Medicine. Since 2003, he has served as the executive director of Burke Neurological Institute and as a member of the Council of Affiliated Deans of Weill Cornell Medicine.

Robert A. Stern is professor of Neurology, Neurosurgery, and Anatomy & Neurobiology at Boston University School of Medicine, where he is also director of clinical research for the BU Chronic Traumatic Encephalopathy (CTE) Center. From 2010 to 2019, he was the director of the Clinical Core of the BU Alzheimer's Disease Center.

David James Burke is an Australian neurologist and clinical neurophysiologist. He has held senior positions at the Prince of Wales Hospital, University of New South Wales and University of Sydney. He led one of two teams that formed the Prince of Wales Medical Research Institute, which was renamed Neuroscience Research Australia in 2010. His career has included a focus on the role of spinal cord circuits in the control of movement, the excitability of peripheral nerve axons in health and disease, and other areas of clinical neurophysiology.

Henry Lauris Paulson is an American neurologist.

Robert Joseph BuchananKM+ is an American neurosurgeon, psychiatrist, and bioethicist who is best known for his contributions to the field of neuroscience, psychosurgery, and neuroethics. He is an associate professor of neurosurgery at Dell Medical School, University of Texas at Austin and maintains courtesy associate professor appointments in the school's department of neurology and department of psychiatry and behavioral sciences.

References

  1. 1 2 3 4 5 6 7 Betzold, Michael (January 26, 2013). "The Corruption of Sid Gilman-How a top U-M doc lost his way". Ann Arbor Observer . Retrieved February 24, 2014.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 "Curriculum Vitae" (PDF). annarbor.com. Sid Gilman. January 12, 2011. Retrieved January 15, 2021.
  3. 1 2 3 4 5 6 7 "Sid Gilman '54, M.D. '57: 1992 Professional Achievement Award". Alumni Association, University of California, Los Angeles. May 28, 2015. Retrieved January 15, 2021.
  4. 1 2 "Sid Gilman, M.D. , FRCP". med.umich.edu. University of Michigan Health System. Archived from the original on June 9, 2010. Retrieved January 15, 2021.
  5. 1 2 3 Popper, Nathaniel; Vlasic, Bill; Steinberg, Stephanie (December 15, 2012). "Quiet Doctor, Lavish Insider: A Parallel Life". The New York Times . Retrieved June 7, 2014.
  6. 1 2 3 4 5 6 7 8 9 10 11 Keefe, Patrick Radden (October 6, 2014). "The Empire of Edge". The New Yorker . Retrieved January 15, 2021.
  7. 1 2 "Dr. Sid Gilman". Doximity.com. Doximity, Inc. Retrieved January 15, 2021.
  8. "Past Recipients of Distinguished University Professorships". rackham.umich.edu. Rackham Graduate School, University of Michigan. Retrieved January 15, 2021.